
Sirio
300791.SZSirio Pharma Co., Ltd. Price (300791.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
180,326,293
(0.8096)%Revenue and Profitability
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 553,771,658 | 698,676,624 | 778,603,687 | 824,439,901 | 786,193,683 | 1,330,464,878 | 1,595,399,576 | 1,579,562,259 | 2,066,817,765 | 2,368,947,616 | 2,507,261,818 | 3,582,022,297 |
Net Income | 45,333,370 | 54,547,989 | 61,449,028 | 56,266,798 | 703,726,194 | 104,299,933 | 203,225,348 | 142,525,251 | 257,366,015 | 231,834,489 | 212,285,578 | 281,038,527 |
FCF USD | -30,512,588 | 60,380,515 | 22,099,584 | -53,701,044 | -170,915,733 | -110,470,657 | -55,867,453 | 64,706,043 | 96,429,828 | -183,306,507 | 151,166,640 | -65,622,267 |
OCF USD | 35,245,900 | 122,504,100 | 90,936,000 | 106,713,900 | -98,263,531 | 49,352,224 | 183,456,193 | 231,604,560 | 319,573,018 | 341,377,365 | 444,859,757 | 386,082,404 |
Financial Health - DEBT
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.95 | 0.45 | 0.19 | 0.21 | 2.14 | 0.78 | 0.23 | 0.00 | 3.75 | 4.38 | 5.43 |
D/E | 0.71 | 0.59 | 1.14 | 1.06 | 0.85 | 0.64 | 0.55 | 0.05 | 0.02 | 0.34 | 0.35 | 0.55 |
CA/CL | 0.94 | 1.01 | 0.66 | 0.75 | 1.04 | 1.24 | 1.09 | 4.37 | 3.42 | 5.76 | 5.18 | 2.57 |
TA/TL | 1.64 | 1.64 | 1.34 | 1.53 | 1.46 | 1.82 | 2.03 | 5.70 | 5.67 | 3.00 | 2.82 | 1.98 |
Total Debt | 118,285,019 | 119,351,552 | 158,151,612 | 256,391,708 | 391,076,487 | 372,697,227 | 430,845,687 | 99,767,525 | 34,709,982 | 874,264,594 | 936,904,848 | 1,305,200,643 |
Management Performance
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC | 15.98% | 18.86% | 23.09% | 9.76% | 75.55% | 9.80% | 16.95% | 6.48% | 11.33% | 6.86% | 6.02% | 5.58% |
ROE | 27.02% | 26.80% | 44.25% | 23.31% | 152.34% | 17.98% | 25.92% | 7.33% | 11.79% | 9.11% | 7.86% | 11.76% |
ROA | 0.00% | 10.45% | 11.27% | 8.10% | 47.72% | 8.10% | 13.17% | 6.04% | 9.71% | 6.07% | 5.07% | 4.62% |
NM % | 8.19% | 7.81% | 7.89% | 6.82% | 89.51% | 7.84% | 12.74% | 9.02% | 12.45% | 9.79% | 8.47% | 7.85% |
FCF / R% | 0.00% | 8.64% | 2.84% | -6.51% | -21.74% | -8.30% | -3.50% | 4.10% | 4.67% | -7.74% | 6.03% | -1.83% |
FCF / NI% | -67.31% | 110.69% | 35.96% | -95.44% | -24.29% | -105.92% | -27.49% | 45.40% | 37.47% | -79.07% | 71.21% | -27.31% |
Operating Margin (OM) | 0.00 | 0.21 | 0.09 | 0.07 | 0.31 | 0.28 | 0.36 | 0.45 | 0.45 | 0.45 | 0.48 | 0.39 |
Per Share
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.00 | 0.00 | 0.00 | 1.32 | 5.21 | 0.77 | 1.51 | 0.79 | 1.43 | 1.29 | 1.18 | 1.56 |
SPS | 0.00 | 0.00 | 0.00 | 19.34 | 5.82 | 9.86 | 11.83 | 8.78 | 11.48 | 13.15 | 13.89 | 19.86 |
OCPS | 0.00 | 0.00 | 0.00 | 2.50 | -0.73 | 0.37 | 1.36 | 1.29 | 1.78 | 1.89 | 2.46 | 2.14 |
FCPS | 0.00 | 0.00 | 0.00 | -1.26 | -1.27 | -0.82 | -0.41 | 0.36 | 0.54 | -1.02 | 0.84 | -0.36 |
BVPS | 0.00 | 0.00 | 0.00 | 5.66 | 3.42 | 4.30 | 5.81 | 10.81 | 12.13 | 14.12 | 14.97 | 14.23 |
Per Share - CAGR
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.00 | 0.00 | 0.00 | 1.32 | 5.21 | 0.77 | 1.51 | 0.79 | 1.43 | 1.29 | 1.18 | 1.56 |
CAGR-SPS | 0.00 | 0.00 | 0.00 | 19.34 | 5.82 | 9.86 | 11.83 | 8.78 | 11.48 | 13.15 | 13.89 | 19.86 |
CAGR-OCPS | 0.00 | 0.00 | 0.00 | 2.50 | -0.73 | 0.37 | 1.36 | 1.29 | 1.78 | 1.89 | 2.46 | 2.14 |
CAGR-FCPS | 0.00 | 0.00 | 0.00 | -1.26 | -1.27 | -0.82 | -0.41 | 0.36 | 0.54 | -1.02 | 0.84 | -0.36 |
CAGR-BVPS | 0.00 | 0.00 | 0.00 | 5.66 | 3.42 | 4.30 | 5.81 | 10.81 | 12.13 | 14.12 | 14.97 | 14.23 |